MacularorRetinalEdema near Mount Vernon, NY

Biography: Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults. Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation. He is a fellow of the American Academy of Ophthalmology, and a member of the Association for Research in Vision and Ophthalmology, the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. He is a Fellow of the Association for Research in Vision and Ophthalmology, and has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education. Dr. Brodie's research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to 80%. Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology's Basic and Clinical Science Course on Clinical Optics for the past eight years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups.

Biography: Qing Wang, MD, PhD, is Assistant Professor of Ophthalmology and a clinician-scientist specializing in the medical and surgical management of glaucoma. Her surgical expertise includes cataract and both minimally invasive and traditional glaucoma surgeries. Her research focus is on understanding why retinal ganglion cells are lost in glaucoma and developing new treatments to protect and restore these cells. Dr. Wang graduated from Yale University with a BS and MS in Molecular Biophysicis and Biochemistry. She subsequently came to Columbia University where she earned her MD and PhD through the Medical Scientist Training Program. Her doctoral dissertation was on the molecular programs that distinguish different subpopulations of retinal ganglion cells during development. She went on to complete her ophthalmology residency and postdoctoral research fellowship on optic nerve regeneration at the Stein Eye Institute at the University of California, Los Angeles. Before returning to Columbia, she completed a glaucoma clinical fellowship at Wilmer Eye Institute at Johns Hopkins University. Dr. Wang is a rising star in glaucoma research and has won many awards throughout her training. Clinically, she is dedicated to addressing the needs of each individual patient to protect their vision and maximize their quality of life.